Last kr3.74 SEK
Change Today -0.04 / -1.06%
Volume 76.8K
MCAP On Other Exchanges
Symbol
Exchange
Stockholm
As of 12:00 PM 07/14/14 All times are local (Market data is delayed by at least 15 minutes).

medcap ab (MCAP) Snapshot

Open
kr3.78
Previous Close
kr3.78
Day High
kr3.78
Day Low
kr3.61
52 Week High
02/17/14 - kr4.49
52 Week Low
07/22/13 - kr2.41
Market Cap
501.2M
Average Volume 10 Days
124.0K
EPS TTM
kr0.19
Shares Outstanding
134.0M
EX-Date
--
P/E TM
19.8x
Dividend
--
Dividend Yield
--
Current Stock Chart for MEDCAP AB (MCAP)

Related News

No related news articles were found.

medcap ab (MCAP) Related Businessweek News

No Related Businessweek News Found

medcap ab (MCAP) Details

MedCap AB is a private equity firm specializing in investments in middle markets, mature, turnarounds, buyouts, mezzanine, and bridge financings. It prefers to invest in medical, medical technology, biotechnology, life sciences, and research companies. The firm prefers to invest in companies that are based in Europe with a main focus on the Nordic region and that are not listed on the stock exchange. It typically invests between SEK50 million ($6.63 million) and SEK200 million ($26.51 million) in companies with an enterprise value between SEK50 million ($6.63 million) and SEK200 million ($26.51 million). The firm seeks to acquire stakes between 20% and 50% in its portfolio companies. It uses its capital and loans and makes balance sheet investments. MedCap AB was founded in 2001 and is based in Stockholm, Sweden.

Founded in 2001

medcap ab (MCAP) Top Compensated Officers

Chief Executive Officer
Total Annual Compensation: kr1.8M
Compensation as of Fiscal Year 2013.

medcap ab (MCAP) Key Developments

MedCap Reports Earnings Results for the First Quarter Ended March 31, 2014

MedCap reported earnings results for the first quarter ended March 31, 2014. For the quarter, the company reported net sales of SEK 223 million compared to SEK 88 million a year ago. Net asset value per share at 31 March 2014 was SEK 1.5. Operating profit rose by SEK 11.7 million to SEK 10.4 million against loss of SEK 1.3 million a year ago.

MedCap AB (publ.) Reports Earnings Results for the Fourth Quarter and Full Year Ended January 04, 2014

MedCap AB (publ.) reported earnings results for the fourth quarter and full year ended January 04, 2014. For the quarter, the company reported net sales of SEK 223 million compared to SEK 88 million a year ago. EBIT was SEK 10.4 million compared to LBIT of SEK 1.3 million a year ago. Profit before tax was SEK 7.4 million compared to loss before tax of SEK 1.5 million a year ago. Profit was SEK 6.5 million compared to loss of SEK 0.7 million a year ago. Cash flow from operating activities was SEK 29 million compared to SEK 43 million a year ago. For the year, the company reported net sales of SEK 659 million compared to SEK 351 million a year ago. EBIT was SEK 32.4 million compared to SEK 21.6 million a year ago. Profit before tax was SEK 23.1 million compared to SEK 21.9 million a year ago. Profit was SEK 20.0 million compared to SEK 18.0 million a year ago. Cash flow from operating activities was SEK 29 million compared to SEK 43 million a year ago. Book value as at December 31, 2013 was SEK 110 million.

MedCap AB (publ.), Annual General Meeting, Aug 30, 2013

MedCap AB (publ.), Annual General Meeting, Aug 30, 2013., at 09:00 Central European Standard Time. Location: Sköldungagatan 4. Agenda: To consider the election of Chairman of the meeting; to elect secretary; to preparation and approval of voting list; to consider election of one or two persons to check the minutes; to consider the presentation of the annual report and the auditors' report and consolidated financial statements and auditor's report for the period May 1, 2012 to April 30, 2013; to consider the decisions on adoption of the balance sheet and income statement and the consolidated balance sheet and consolidated income statement for the period May 1, 2012 to April 30, 2013, allocation of the company's profit or loss according to the adopted balance sheet, and discharge the board and Chief Executive Officer; to consider the determination of the remuneration to the board and the auditor; to consider the election of directors, deputy directors and auditors; to issue authorization; to consider the regarding incentive program for executives in subsidiaries; and to consider the closing of the meeting.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MCAP:SS kr3.74 SEK -0.04

MCAP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MCAP.
View Industry Companies
 

Industry Analysis

MCAP

Industry Average

Valuation MCAP Industry Range
Price/Earnings 19.6x
Price/Sales 0.5x
Price/Book 2.1x
Price/Cash Flow 10.3x
TEV/Sales 0.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDCAP AB, please visit www.medcap.se. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.